Spots Global Cancer Trial Database for chordoma
Every month we try and update this database with for chordoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Prospective Study of Surgical Treatment Strategies for Chordoma | NCT05707767 | Chordoma of Spi... Surgery | Resection surge... | 18 Years - 70 Years | Xuanwu Hospital, Beijing | |
| Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | NCT03623854 | Chordoma Locally Advance... Metastatic Chor... Unresectable Ch... | Nivolumab Relatlimab | 12 Years - | Jonsson Comprehensive Cancer Center | |
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers | NCT03190174 | Ewing Sarcoma PEComa Epithelioid Sar... Desmoid Tumor Chordoma Non Small Cell ... Urothelial Carc... Melanoma Renal Cell Carc... Squamous Cell C... Hepatocellular ... Classical Hodgk... Colorectal Canc... MTOR Activating... | Nab-Rapamycin Nivolumab | 12 Years - | Sarcoma Oncology Research Center, LLC | |
| Ion Irradiation of Sacrococcygeal Chordoma | NCT01811394 | Sacral Chordoma | protons carbon ions | 18 Years - 80 Years | Heidelberg University | |
| A Prospective Study of Surgical Treatment Strategies for Chordoma | NCT05707767 | Chordoma of Spi... Surgery | Resection surge... | 18 Years - 70 Years | Xuanwu Hospital, Beijing | |
| Children and Adults With Chordoma | NCT03910465 | Chordoma | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma | NCT02383498 | Chordoma | Placebo GI-6301 Vaccine... Radiotherapy wGT3X-BT Actigr... | 18 Years - 100 Years | NantCell, Inc. | |
| Proton Beam Therapy for Chordoma Patients | NCT00496119 | Chordoma | Proton Beam The... Photon Beam The... | - | M.D. Anderson Cancer Center | |
| Pemetrexed for the Treatment of Chordoma | NCT03955042 | Chordoma | Pemetrexed | 18 Years - | Saint John's Cancer Institute | |
| Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma | NCT04042597 | Effect of Drugs Quality of Life Chordoma Advanced Cancer | Anlotinib Hydro... | 18 Years - | Peking University People's Hospital | |
| Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas | NCT01567046 | Childhood Alveo... Childhood Angio... Childhood Desmo... Childhood Epith... Childhood Fibro... Childhood Leiom... Childhood Lipos... Childhood Malig... Childhood Neuro... Childhood Synov... Chordoma Desmoid Tumor Metastatic Chil... Nonmetastatic C... Recurrent Child... | laboratory biom... | - 30 Years | Children's Oncology Group | |
| Image Assisted Optimization of Proton Radiation Therapy in Chordomas and Chondrosarcomas | NCT04832620 | Bone Neoplasm o... Chordoma Chondrosarcoma Magnetic Resona... PET-CT Proton Therapy | 50 Years - | Leiden University Medical Center | ||
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| BN Brachyury and Radiation in Chordoma | NCT03595228 | Chordoma | BN-Brachyury pl... | 12 Years - 99 Years | Bavarian Nordic | |
| Immunohistochemical Study of Chordomas to Improve Their Diagnosis and Prognosis Care | NCT04486820 | Chordoma | Analysis Immuno... | - | Centre Hospitalier Universitaire de Saint Etienne | |
| Apatinib Combined With Camrelizumab in Treating Participants With Advanced Chordoma | NCT06140732 | Chordoma Chemotherapy Ef... | camrelizumab an... | 18 Years - | Xuanwu Hospital, Beijing | |
| Ion Irradiation of Sacrococcygeal Chordoma | NCT01811394 | Sacral Chordoma | protons carbon ions | 18 Years - 80 Years | Heidelberg University | |
| Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma | NCT05041127 | Chordoma Metastatic Chor... Unresectable Ch... | Cetuximab Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| BN Brachyury and Radiation in Chordoma | NCT03595228 | Chordoma | BN-Brachyury pl... | 12 Years - 99 Years | Bavarian Nordic | |
| Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma | NCT01175109 | Chordoma | Imatinib + LBH5... | 18 Years - | University of Virginia | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| Chordoma Family Study | NCT00410670 | Chordoma | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma | NCT00919269 | Adult Rhabdomyo... Childhood Desmo... Chordoma Desmoid-Type Fi... Metastatic Chil... Non-Metastatic ... Previously Trea... Recurrent Adult... Recurrent Child... Recurrent Child... Rhabdomyosarcom... Stage I Adult S... Stage II Adult ... Stage III Adult... Stage IV Adult ... Untreated Child... | Cytology Specim... Laboratory Biom... | - 50 Years | Children's Oncology Group | |
| CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma | NCT03110744 | Chordoma | Palbociclib | 18 Years - | University Hospital Heidelberg | |
| Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors | NCT00003926 | Brain and Centr... Childhood Germ ... Chordoma Kidney Cancer Liver Cancer Neuroblastoma Ovarian Cancer Retinoblastoma Sarcoma | amifostine trih... busulfan filgrastim melphalan thiotepa peripheral bloo... | 1 Year - 45 Years | Masonic Cancer Center, University of Minnesota | |
| A Prospective Study of Surgical Treatment Strategies for Chordoma | NCT05707767 | Chordoma of Spi... Surgery | Resection surge... | 18 Years - 70 Years | Xuanwu Hospital, Beijing | |
| Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies | NCT01924689 | Solid Tumor Mal... | Clostridium nov... | 18 Years - | BioMed Valley Discoveries, Inc | |
| Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma | NCT02989636 | Chordoma | Laboratory Biom... Nivolumab Stereotactic Ra... | 15 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors | NCT05355753 | Synovial Sarcom... Soft Tissue Sar... | CFT8634 | 12 Years - | C4 Therapeutics, Inc. | |
| Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate | NCT01046487 | Cancer | Imatinib mesyla... Imatinib mesyla... Imatinib mesyla... Blood sampling | 18 Years - | Centre Oscar Lambret | |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma | NCT02520128 | Soft Tissue Sar... Ewing Sarcoma Bone Sarcoma Chordoma | Intensity modul... | 16 Years - | University College, London | |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | NCT02834013 | Acinar Cell Car... Adenoid Cystic ... Adrenal Cortica... Adrenal Gland P... Anal Canal Neur... Anal Canal Undi... Angiosarcoma Apocrine Neopla... Appendix Mucino... Bartholin Gland... Basal Cell Carc... Bladder Adenoca... Breast Metaplas... Cervical Adenoc... Cholangiocarcin... Chordoma Colorectal Squa... Desmoid Fibroma... Endometrial Tra... Endometrioid Ad... Esophageal Neur... Esophageal Undi... Extrahepatic Bi... Extramammary Pa... Fallopian Tube ... Fallopian Tube ... Fibromyxoid Tum... Gallbladder Car... Gastric Neuroen... Gastric Squamou... Gastric Undiffe... Gastrointestina... Gestational Tro... Giant Cell Carc... Human Papilloma... Intestinal Neur... Intrahepatic Ch... Lung Neuroendoc... Lung Sarcomatoi... Major Salivary ... Malignant Odont... Malignant Perip... Malignant Solid... Malignant Testi... Metastatic Mali... Metastatic Pitu... Minimally Invas... Mixed Mesoderma... Mucinous Adenoc... Mucinous Cystad... Nasal Cavity Ad... Nasal Cavity Ca... Nasopharyngeal ... Nasopharyngeal ... Nasopharyngeal ... Oral Cavity Car... Oropharyngeal U... Ovarian Adenoca... Ovarian Germ Ce... Ovarian Mucinou... Ovarian Squamou... Ovarian Transit... Pancreatic Acin... Pancreatic Neur... Paraganglioma Paranasal Sinus... Paranasal Sinus... Parathyroid Gla... PEComa Penile Squamous... Peritoneal Meso... Placental Chori... Primary Periton... Pseudomyxoma Pe... Rare Disorder Scrotal Squamou... Seminal Vesicle... Seminoma Serous Cystaden... Small Intestina... Small Intestina... Spindle Cell Ne... Teratoma With S... Testicular Non-... Thyroid Gland C... Tracheal Carcin... Transitional Ce... Ureter Adenocar... Ureter Squamous... Urethral Adenoc... Urethral Squamo... Vaginal Adenoca... Vaginal Squamou... Vulvar Carcinom... | Biospecimen Col... Computed Tomogr... Echocardiograph... Ipilimumab Magnetic Resona... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Hypofractionated Protontherapy in Chordomas and Chondrosarcomas of the Skull Base | NCT05861245 | Chordoma Chondrosarcoma | 5-fraction hipo... | 18 Years - | Quironsalud | |
| Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma | NCT02989636 | Chordoma | Laboratory Biom... Nivolumab Stereotactic Ra... | 15 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine | NCT00592748 | Chordoma Chondrosarcoma | Charged Particl... | 18 Years - | Massachusetts General Hospital | |
| Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base | NCT01182779 | Chordoma Tumor Treatment | Carbon ion Protons | 18 Years - 80 Years | Heidelberg University | |
| Chordoma Family Study | NCT00410670 | Chordoma | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Efficacy and Safety of Imatinib in Chordoma | NCT00150072 | Chordoma | imatinib | - | Novartis | |
| Chordoma Family Study | NCT00410670 | Chordoma | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | ||
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Long-Term Longitudinal QoL in Patients Undergoing EEA | NCT04087902 | Pituitary Tumor Meningioma Rathke Cleft Cy... Chordoma Chondrosarcoma Craniopharyngio... Encephalocele Esthesioneurobl... | 18 Years - | Ohio State University | ||
| QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma | NCT02383498 | Chordoma | Placebo GI-6301 Vaccine... Radiotherapy wGT3X-BT Actigr... | 18 Years - 100 Years | NantCell, Inc. | |
| Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone | NCT05033288 | Bone Sarcoma Chondrosarcoma Chordoma Ewing Sarcoma o... Pelvic Rhabdomy... | Electronic Heal... Quality-of-Life... | 15 Years - | Mayo Clinic | |
| Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy | NCT06029218 | Chordoma Chondrosarcoma Ewing Sarcoma Osteosarcoma | Proteus ONE one... Proteus ONE two... | 18 Years - | Centre Antoine Lacassagne | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Afatinib in Locally Advanced and Metastatic Chordoma | NCT03083678 | Chordoma | Afatinib | 18 Years - | Leiden University Medical Center | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| CDK4/6 Inhibition in Locally Advanced/Metastatic Chordoma | NCT03110744 | Chordoma | Palbociclib | 18 Years - | University Hospital Heidelberg | |
| Efficacy and Safety of Imatinib in Chordoma | NCT00150072 | Chordoma | imatinib | - | Novartis | |
| Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma | NCT03623854 | Chordoma Locally Advance... Metastatic Chor... Unresectable Ch... | Nivolumab Relatlimab | 12 Years - | Jonsson Comprehensive Cancer Center | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Nilotinib With Radiation for High Risk Chordoma | NCT01407198 | Chordoma | Nilotinib Radiation thera... | 18 Years - | Massachusetts General Hospital | |
| Tazemetostat+Nivo/Ipi in INI1-Neg/SMARCA4-Def Tumors | NCT05407441 | Atypical Terato... INI1 (SMARCB1)-... SMARCA4-deficie... Malignant Rhabd... Rhabdoid Tumor ... Epithelioid Sar... Chordoma | Tazemetostat Nivolumab Ipilimumab | 6 Months - 21 Years | Dana-Farber Cancer Institute | |
| Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families | NCT00341627 | Chordoma | - 110 Years | National Institutes of Health Clinical Center (CC) | ||
| Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma | NCT04042597 | Effect of Drugs Quality of Life Chordoma Advanced Cancer | Anlotinib Hydro... | 18 Years - | Peking University People's Hospital | |
| Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas | NCT01567046 | Childhood Alveo... Childhood Angio... Childhood Desmo... Childhood Epith... Childhood Fibro... Childhood Leiom... Childhood Lipos... Childhood Malig... Childhood Neuro... Childhood Synov... Chordoma Desmoid Tumor Metastatic Chil... Nonmetastatic C... Recurrent Child... | laboratory biom... | - 30 Years | Children's Oncology Group | |
| Trial of Palbociclib in Second Line of Advanced Sarcomas With CDK4 Overexpression. | NCT03242382 | Soft-tissue Sar... Osteosarcoma Chordoma | Palbociclib | 18 Years - 80 Years | Grupo Espanol de Investigacion en Sarcomas |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
